Correlation Between Black Diamond and Akero Therapeutics
Can any of the company-specific risk be diversified away by investing in both Black Diamond and Akero Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Black Diamond and Akero Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Black Diamond Therapeutics and Akero Therapeutics, you can compare the effects of market volatilities on Black Diamond and Akero Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Black Diamond with a short position of Akero Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Black Diamond and Akero Therapeutics.
Diversification Opportunities for Black Diamond and Akero Therapeutics
0.28 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Black and Akero is 0.28. Overlapping area represents the amount of risk that can be diversified away by holding Black Diamond Therapeutics and Akero Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Akero Therapeutics and Black Diamond is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Black Diamond Therapeutics are associated (or correlated) with Akero Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Akero Therapeutics has no effect on the direction of Black Diamond i.e., Black Diamond and Akero Therapeutics go up and down completely randomly.
Pair Corralation between Black Diamond and Akero Therapeutics
Given the investment horizon of 90 days Black Diamond is expected to generate 5.19 times less return on investment than Akero Therapeutics. But when comparing it to its historical volatility, Black Diamond Therapeutics is 3.18 times less risky than Akero Therapeutics. It trades about 0.15 of its potential returns per unit of risk. Akero Therapeutics is currently generating about 0.25 of returns per unit of risk over similar time horizon. If you would invest 2,661 in Akero Therapeutics on November 8, 2024 and sell it today you would earn a total of 3,095 from holding Akero Therapeutics or generate 116.31% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 95.24% |
| Values | Daily Returns |
Black Diamond Therapeutics vs. Akero Therapeutics
Performance |
| Timeline |
| Black Diamond Therap |
| Akero Therapeutics |
Black Diamond and Akero Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Black Diamond and Akero Therapeutics
The main advantage of trading using opposite Black Diamond and Akero Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Black Diamond position performs unexpectedly, Akero Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Akero Therapeutics will offset losses from the drop in Akero Therapeutics' long position.| Black Diamond vs. Passage Bio | Black Diamond vs. Alector | Black Diamond vs. Revolution Medicines | Black Diamond vs. Stoke Therapeutics |
| Akero Therapeutics vs. Terns Pharmaceuticals | Akero Therapeutics vs. Madrigal Pharmaceuticals | Akero Therapeutics vs. Inozyme Pharma | Akero Therapeutics vs. Viking Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Other Complementary Tools
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |